Keros Therapeutics, Inc. Investing Cash Flow
Keros Therapeutics, Inc. (KROS) reported Investing Cash Flow of -$228.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-03
- Keros Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$155.00K.
- Keros Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$73.00K.
- Keros Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$134.00K.
- Keros Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$132.00K.
- Keros Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$1.55M.
- Keros Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$1.93M.
- Keros Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$2.46M.
- Keros Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$1.24M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$228.00K 10-Q · filed 2026-08-03 | -$362.00K derived: sum of 3 quarters · filed 2026-08-03 | -$494.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$73.00K 10-Q · filed 2026-05-14 | -$207.00K derived: sum of 2 quarters · filed 2026-05-14 | -$339.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.06M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$266.00K derived: sum of 2 quarters · filed 2026-03-04 | -$986.00K derived: sum of 3 quarters · filed 2026-08-03 | -$1.55M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$852.00K derived: sum of 2 quarters · filed 2026-08-03 | -$1.42M 10-Q · filed 2025-11-05 | -$1.71M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$720.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$1.28M 10-Q · filed 2026-08-03 | -$1.57M derived: sum of 3 quarters · filed 2026-08-03 | -$1.96M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$565.00K 10-Q · filed 2026-05-14 | -$854.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.24M derived: sum of 3 quarters · filed 2026-05-14 | -$1.55M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$675.00K derived: sum of 2 quarters · filed 2026-03-04 | -$985.00K derived: sum of 3 quarters · filed 2026-03-04 | -$1.93M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$696.00K derived: sum of 2 quarters · filed 2025-11-05 | -$1.64M 10-Q · filed 2025-11-05 | -$2.18M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$310.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.26M 10-Q · filed 2025-08-06 | -$1.80M derived: sum of 3 quarters · filed 2025-08-06 | -$2.35M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$946.00K 10-Q · filed 2025-05-06 | -$1.49M derived: sum of 2 quarters · filed 2025-05-06 | -$2.04M derived: sum of 3 quarters · filed 2025-05-06 | -$2.35M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$1.09M derived: sum of 2 quarters · filed 2025-02-26 | -$1.40M derived: sum of 3 quarters · filed 2025-02-26 | -$2.46M 10-K · filed 2025-02-26 |
| 2023-09-30 | -$550.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$861.00K derived: sum of 2 quarters · filed 2024-11-06 | -$1.92M 10-Q · filed 2024-11-06 | -$2.27M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$311.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.37M 10-Q · filed 2024-08-07 | -$1.72M derived: sum of 3 quarters · filed 2025-02-26 | -$1.90M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$1.06M 10-Q · filed 2024-05-08 | -$1.41M derived: sum of 2 quarters · filed 2025-02-26 | -$1.59M derived: sum of 3 quarters · filed 2025-02-26 | -$2.16M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$527.00K derived: sum of 2 quarters · filed 2025-02-26 | -$1.09M derived: sum of 3 quarters · filed 2025-02-26 | -$1.24M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$743.00K derived: sum of 2 quarters · filed 2023-11-06 | -$890.00K 10-Q · filed 2023-11-06 | -$1.05M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$567.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$714.00K 10-Q · filed 2023-08-07 | -$873.00K derived: sum of 3 quarters · filed 2024-02-28 | -$1.02M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$147.00K 10-Q · filed 2023-05-04 | -$306.00K derived: sum of 2 quarters · filed 2024-02-28 | -$451.00K derived: sum of 3 quarters · filed 2024-02-28 | -$961.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$304.00K derived: sum of 2 quarters · filed 2024-02-28 | -$814.00K derived: sum of 3 quarters · filed 2024-02-28 | -$1.02M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$655.00K derived: sum of 2 quarters · filed 2022-11-03 | -$865.00K 10-Q · filed 2022-11-03 | -$925.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$720.00K 10-Q · filed 2022-08-04 | -$780.00K derived: sum of 3 quarters · filed 2022-08-04 | -$810.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$210.00K 10-Q · filed 2022-05-05 | -$270.00K derived: sum of 2 quarters · filed 2022-05-05 | -$300.00K derived: sum of 3 quarters · filed 2022-05-05 | -$328.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$90.00K derived: sum of 2 quarters · filed 2022-03-09 | -$118.00K derived: sum of 3 quarters · filed 2022-03-09 | -$294.00K 10-K · filed 2022-03-09 |
| 2020-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$58.00K derived: sum of 2 quarters · filed 2021-11-04 | -$234.00K 10-Q · filed 2021-11-04 | -$252.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$204.00K 10-Q · filed 2021-08-05 | -$222.00K derived: sum of 3 quarters · filed 2021-08-05 | -$304.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$176.00K 10-Q · filed 2021-05-06 | -$194.00K derived: sum of 2 quarters · filed 2021-05-06 | -$276.00K derived: sum of 3 quarters · filed 2021-05-06 | -$447.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$100.00K derived: sum of 2 quarters · filed 2021-03-25 | -$271.00K derived: sum of 3 quarters · filed 2021-03-25 | -$271.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$253.00K derived: sum of 2 quarters · filed 2020-11-10 | -$253.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$171.00K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |